qpx2014
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 28, 2020 (NCT04380207)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Renal dipeptidaseINHIBITOR
DPEP1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05072444 | Phase 1 | Nov 15, 2021 | Department of Health and Human Services, Qpex Biopharma, Inc. |
| NCT04380207 | Phase 1 | Sep 28, 2020 | Department of Health and Human Services, Qpex Biopharma, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Department of Health and Human Services | Government | 2 | 0 | 1 | 2020 |
| Qpex Biopharma, Inc. | For profit | 2 | 2 | 1 | 2020 |
2 organizations
Page 1 / 1